Facial Injectables Market By Product Type (Dermal Fillers, Botox), By End-user (Hospitals, Dermatology Centers, Physician's Office), By Region (North America, Europe, Asia Pacific, RoW) – Global Forecast up to 2025
-
Product Code:
RP-ID-10325825 -
Published Date:
21 Oct 2022 -
Region:
Global
-
Pages:
102 -
Category:
Healthcare & Pharmaceuticals -
Publisher:
Pub-ID-15
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.
....
The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Market Overview:
Translate Report
Global Facial Injectables Market by Product Types (Dermal
Fillers, Botox), By End-users (Hospitals, Dermatology Centers,
Physician’s Office), and By Regions (North America, Europe,
Asia Pacific, and Rest of the World) – Global Forecast up to
2025
This market research report includes a detailed segmentation of the global facial
injectables market by product types (dermal fillers and Botox), by end-users
(hospitals, dermatology centers, and physician’s office), and by regions (North
America, Europe, APAC, and RoW).
Research Overview
Infoholic Research predicts that the global facial injectables market will grow at a
CAGR of 10.81% during the forecast period 2019–2025. Facial injectables refer to the
aesthetic treatment of the skin that results in a more youthful look. There are a
variety of aesthetic procedures performed, including those used to treat skin
conditions (deep lines & wrinkles), change the contours of jaw or lips, scars &
depressions in the skin resulting from acne, congenital or injury imperfections, etc.
Dermal fillers and Botox are the top-leading products used to treat these skin
conditions. Dermal fillers offer treatment to face, neck, and hands, thereby resulting
in a smooth, fuller, and more youthful look. Dermal fillers are increasingly being
adopted due to immediate positive results, which have become popular globally.
There are temporary fillers that are absorbed by the body and are classified into
collagen-based fillers, hyaluronic acid-based fillers, calcium hydroxylapatite, and
poly-L-lactic acid. These have provisional results and are used every 4–6 months.
Permanent fillers are made of polymethylmethacrylate (PMMA), which are not
absorbed by the body. ArteFill is among the most common brand used as
permanent fillers.
An increase in beauty consciousness, growing awareness about facial injections,
increasing demand for non-surgical & minimally invasive cosmetic surgeries, and
anticipated launch of new products are expected to drive the market growth during
the forecast period. The market is also witnessing few emerging trends, including
increase in demand for combination treatments, rise in medical tourism, and
increasing disposable income, which will drive the market at a significant pace
during the forecast period. The facial injectables market in Brazil, India, China, and
Russia is also expected to grow at a rapid pace during the forecast period as the
adoption of cosmetic procedures in these countries is high.
Most of the vendors are focusing on evidence-based clinical results for the
development and advancement of the product. The advancements in technology,
the emergence of innovative products with the adoption of minimally invasive
procedures, and the demand for facial injectables for the treatment of various skin
conditions are driving the market growth.
•Advancementsininjectableneedleshaveresultedintheemergenceofmolecularchangesandalterationinviscoelasticpropertiesofnew-generationfillersusingthehybridmatrixorVycrosstechnologieswith3Dcross-linkingtogiveGprimefillers•IncreaseindemandforcombinationtreatmentsOpportunities
Challenges•Highcostofinjectablesandfrequencyofadoptionarechallenges•Complicationsandrisksassociatedwithfacialinjectablesmayleadtoadverseeffects,i.e.,stroke,blindness,visionimpairment,orevendeathinrarecases
Trends•Increaseinthepreferenceforminimallyinvasiveproceduresindermatologyisduetoaffordabilityandeffectivenessofthetreatment•Increaseindisposableincomehasledtotheincreasedadoptionrateexponentiallyoverthepastyears
Market dynamics
•Thetrendofselfies,especiallyindevelopedcountries(US,France,Germany,Italy),hascontributedtotheincreaseinthenumberofcosmeticsurgeriesasmanypeoplearebecominghyper-awareoftheirimages•Cosmeticsurgeriesarenolongerawomen-specificdomain;thereisanincreaseintheadoptionofcosmeticsurgeriesfrommenindevelopedcountries•Botoxinjectionsareupby36%since2014CAGR: 10.81% (2019–2025)
> 47% market shareKey Highlights
The market is fueled by innovation and new technological techniques & procedures.
The presence of large, small, and local vendors in the market has led to high
competition among them. The global facial injectables market is dominated by
Allergan, Galderma, Merz Pharma, and Ipsen. These vendors are consistently
increasing their footprint in the market; regional vendors are finding it more difficult
to compete with larger players, especially on quality, pricing, market reach, and
financial resources. Further, they are expanding their inorganic growth by acquiring
regional or local players.
Segmentation by Product Types:
ï‚· Dermal Fillers
ï‚· Botox
The market players compete on various factors: price, availability, brand, and
variety. Price is set to become a major base for competition among players
specializing in certain products to gain an edge in the market. The companies with
better-skilled workforce and financial resources are able to manufacture products
that may render competitors merchandise non-competitive even before they are
launched. This makes it difficult for the latter to recover R&D and commercialization
costs. As a result, vendors must develop new products and stay abreast of emerging
market trends that influence their product lines.
Segmentation by End-users:
ï‚· Hospitals
ï‚· Dermatology Centers
ï‚· Physician’s Office
In 2018, dermatology centers gained the highest share in the facial injectables
market with a large volume of cosmetic treatments globally.
Segmentation by Regions:
ï‚· North America
ï‚· Europe
ï‚· Asia Pacific
ï‚· RoW
Geography Analysis:
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
.
Please enter your personal details below
Allergan plc
Galderma
Merz Pharma GmbH & Co. KGaA
Ipsen S.A.